Exploring vasomotor mechanisms using new PKG inhibitors
Project Number5R01HL068991-03
Contact PI/Project LeaderDOSTMANN, WOLFGANG R
Awardee OrganizationUNIVERSITY OF VERMONT & ST AGRIC COLLEGE
Description
Abstract Text
DESCRIPTION (provided by applicant): Cyclic GMP-dependent protein kinase (PKG)
plays a central role in the regulation of vascular smooth muscle tone.
Activation of PKG leads to alterations in intracellular Ca2+, which in turn,
effects multiple cellular signaling pathways. However, progress in
understanding the specific functional roles of PKG in vascular smooth muscle
has been hampered by the lack of specific PKG inhibitors. We have developed
novel, cell-permeable PKG specific peptide inhibitors with unprecedented
potency and kinase specificity by fusion of peptides derived from combinatorial
libraries with membrane translocation signal (MTS) peptides. These fusion
peptides result in an extraordinary synergism with respect to PKG inhibition.
In the proposed experiments, these PKG selective inhibitors will be further
developed, refined and used to study specific functional roles of PKG in
vascular smooth muscle. Specific Aim 1 will develop novel peptide library
design strategies based on binding- and competition libraries. This approach
should lead to new and mole potent PKG inhibitors than are currently available.
Specific Aim 2 will explore variations of the MTS sequences with respect to
their use for intracellular delivery and their ability to synergize with the
library derived peptide inhibitors. Specific Aim 3 will determine the
contributions of PKG in the regulation of vascular tone in intact resistance
arteries by measuring the effects of PKG inhibitors on arterial diameter as
well as ion channel activity in single vascular smooth muscle cells. To pursue
the aims of this proposal, a multi-faceted approach will be used, including
state-of-the-art techniques to: 1) screen and synthesize selective PKG
inhibitor peptides using combinatorial library approaches, 2) deliver peptide
inhibitors using membrane translocation peptide sequences and monitor the
intracellular accumulation of these compounds using kinase activity assays,
fluorescence spectroscopy and confocal microscopy, and 3) assess the efficacy
of the PKG inhibitors using functional assays of ion channel activity (patch
clamp) and vascular contractility (myography). The studies outlined above will
provide new, selective, and potent inhibitors of PKG which will be useful in
revealing the fundamental physiological roles of PKG in regulation of arterial
tone. The application of the inhibitors that emerge from these studies will not
only demonstrate the essential role of PKG in regulation of vascular tone in
resistance arteries, but also significantly advance the field of protein kinase
signaling in general. This work may also suggest novel targets for therapeutic
interventions in vascular diseases such as hypertension and septic shock.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Escherichia coliSDS polyacrylamide gel electrophoresisSf9 cell linebiological signal transductioncGMP dependent protein kinasecalcium channelchemical kineticscombinatorial chemistryconfocal scanning microscopyenzyme inhibitorsenzyme mechanismfluorescent dye /probeintracellular transportmembrane permeabilitymembrane potentialspeptide chemical synthesispeptide librarypotassium channelradiotracertissue /cell culturevascular endotheliumvascular smooth musclevasoconstrictionvoltage /patch clampwestern blottings
No Sub Projects information available for 5R01HL068991-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL068991-03
Patents
No Patents information available for 5R01HL068991-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL068991-03
Clinical Studies
No Clinical Studies information available for 5R01HL068991-03
News and More
Related News Releases
No news release information available for 5R01HL068991-03
History
No Historical information available for 5R01HL068991-03
Similar Projects
No Similar Projects information available for 5R01HL068991-03